Pretreatment maximum standardized uptake value of (18)F-fluorodeoxyglucose positron emission tomography as a predictor of distant metastasis in adenoid cystic carcinoma of the head and neck

Head Neck. 2016 May;38(5):755-61. doi: 10.1002/hed.23953. Epub 2015 May 26.

Abstract

Background: The purpose of this study was to determine whether the maximum standardized uptake value (SUVmax) of the primary tumor on pretreatment (18)F-fluorodeoxyglucose positron emission tomography ((18)F-FDG PET) has prognostic significance in patients with adenoid cystic carcinoma (ACC) of the head and neck.

Methods: A retrospective review was carried out on 34 patients with ACC of the head and neck who underwent pretreatment (18)F-FDG PET imaging from June 2005 through July 2009. All patients underwent surgery with curative intent, and 26 of them received adjuvant radiotherapy (RT).

Results: When subjects were stratified into 2 groups according to a cutoff value for SUVmax of 4.15, the risk of distant metastasis was significantly high in patients with high SUVmax (p = .014). Multivariate analysis showed that high SUVmax and histologic grade 3 were independent poor prognostic factors for distant metastasis-free and disease-free survival.

Conclusion: Pretreatment SUVmax of the primary tumor is an independent prognostic factor in patients with ACC of the head and neck.

Keywords: 18F-fluorodeoxyglucose positron emission tomography (FDG PET); adenoid cystic carcinoma; head and neck cancer; prognosis; standardized uptake value.

MeSH terms

  • Adult
  • Aged
  • Carcinoma, Adenoid Cystic / diagnostic imaging*
  • Carcinoma, Adenoid Cystic / mortality
  • Carcinoma, Adenoid Cystic / secondary*
  • Female
  • Fluorodeoxyglucose F18 / administration & dosage*
  • Follow-Up Studies
  • Head and Neck Neoplasms / diagnostic imaging*
  • Head and Neck Neoplasms / mortality
  • Head and Neck Neoplasms / pathology*
  • Humans
  • Male
  • Middle Aged
  • Positron-Emission Tomography / methods*
  • Prognosis
  • ROC Curve
  • Radiopharmaceuticals / administration & dosage*
  • Retrospective Studies
  • Survival Analysis
  • Young Adult

Substances

  • Radiopharmaceuticals
  • Fluorodeoxyglucose F18